Joseph A. DiMasi - Publications, H-index & Citations

Joseph A. DiMasi

tufts university

33H指数

92论文数

1.4W被引数

收录论文 29

发表时间

Postapproval Innovation For Oncology Drugs And The Inflation Reduction Act

HEALTH AFFAIRS

IF8.1

2024-10-01

PREAI

Grabowski, Henry; Dimasi, Joseph A.; Long, Genia

Assessing the net financial benefits of employing digital endpoints in clinical trials

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2024-07-28

OAAI

DiMasi, Joseph A.; Dirks, Abigail; Smith, Zachary; Valentine, Sarah; Goldsack, Jennifer C.; Metcalfe, Thomas; Grewal, Upinder; Leyens, Lada; Conradi, Ute; Karlin, Daniel; Maloney, Lesley; Getz, Kenneth A.; Hartog, Bert

Impact of regulatory system changes on the availability of innovative drugs in China

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2023-04-14

PREAI

Ge, Qianwei; Xu, Lili; DiMasi, Joseph A.; Kaitin, Kenneth I.; Shao, Liming

Strategic, feasibility, economic, and cultural aspects of phase 0 approaches Is it time to change the drug development process in order to increase productivity?0阶段方法的战略、可行性、经济和文化方面是时候改变药物开发过程以提高生产率了吗？

CTS-CLINICAL AND TRANSLATIONAL SCIENCE

IF2.8

2022-04-21

OAAI

Burt, Tal; Roffel, Ad F.; Langer, Oliver; Anderson, Kirsten; DiMasi, Joseph

The failure to fail smartly

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2020-09-23

PREAI

Galson, Steven; Austin, Christopher P.; Khandekar, Eeshan; Hudson, Lynn D.; DiMasi, Joseph A.; Califf, Robert; Wagner, John A.

Development Times and Approval Success Rates for Drugs to Treat Infectious Diseases

CLINICAL PHARMACOLOGY & THERAPEUTICS

IF5.5

2019-10-11

PREAI

DiMasi, Joseph A.; Florez, Maria, I; Stergiopoulos, Stella; Pena, Yaritza; Smith, Zachary; Wilkinson, Michael; Getz, Kenneth A.

Assessing the Financial Benefits of Faster Development Times: The Case of Single-source Versus Multi-vendor Outsourced Biopharmaceutical Manufacturing

CLINICAL THERAPEUTICS

IF3.6

2018-06-01

PREAI

DiMasi, Joseph A.; Smith, Zachary; Getz, Kenneth A.

Cost Drivers of a Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial Pneumonia Phase 3 Clinical Trial 医院获得性细菌性肺炎和呼吸机相关细菌性肺炎3期临床试验的成本驱动因素

CLINICAL INFECTIOUS DISEASES

IF7.3

2017-08-17

OAAI

Stergiopoulos, Stella; Calvert, Sara B.; Brown, Carrie A.; Awatin, Josephine; Tenaerts, Pamela; Holland, Thomas L.; DiMasi, Joseph A.; Getz, Kenneth A.

Landscape of Innovation for Cardiovascular Pharmaceuticals: From Basic Science to New Molecular Entities

CLINICAL THERAPEUTICS

IF3.6

2017-07-01

PREAI

Beierlein, Jennifer M.; McNamee, Laura M.; Walsh, Michaell J.; Kaitin, Kenneth I.; DiMasi, Joseph A.; Ledley, Fred D.

Investigating investment in biopharmaceutical R&D

NATURE REVIEWS DRUG DISCOVERY

IF101.8

2016-09-12

OAAI

Carter, Percy H.; Berndt, Ernst R.; DiMasi, Joseph A.; Trusheim, Mark